Fate Therapeutics (FATE) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.52
-0.46
-0.39
-0.33

Details

Expected EPS
-0.416457
Actual EPS
-0.4
Surprise EPS
0.02
Surprise Percent
+3.95%

Description

⁨Fate Therapeutics⁩ (⁦FATE⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts